ICDs (implantable cardioverter defibrillators) give Medtronic earnings boost at start of FY2005
This article was originally published in Clinica
Executive Summary
Boasting 31% growth in sales for the first quarter, Medtronic's implantable cardioverter defibrillator (ICD) business got off to an auspicious start for fiscal 2005. Despite shortfalls in the company's other businesses, the star performance by its ICD franchise pulled the group's quarterly net earnings up to $529.7m - an 18% increase from the first quarter last year - and enabled the company to meet analysts' estimates.